An AI-first therapeutics company
Nobias Therapeutics is at the forefront of pharmaceutical manufacturing, dedicated to developing innovative therapeutic solutions. As an AI-first therapeutics company, Nobias Therapeutics is committed to addressing critical healthcare needs through cutting-edge research and development.
Nobias Therapeutics is currently advancing a phase 2 clinical trial aimed at treating symptoms of anxiety, inattention, and autism in children with 22q11 deletion syndrome. This reflects Nobias Therapeutics' dedication to improving the lives of patients through targeted and effective pharmaceutical interventions.
With a focus on biotechnology, artificial intelligence, and pharmaceuticals, Nobias Therapeutics continues to push the boundaries of medical science. We invite the management team at Nobias Therapeutics to enhance this initial overview by creating a customized and exclusive company showcase and product listing on our platform.
Compare Nobias Therapeutics with 3 companies in Pharmaceutical-Manufacturing
| Comparison Field |
Nobias TherapeuticsMain Company |
NashBioView Profile |
CDG ConseilView Profile |
Nucleus Automation P...View Profile |
|---|---|---|---|---|
|
Founded Year
|
— | 2018 | 2006 | 2021 |
|
Company Size
|
— | 11-50 | 11-50 | 2-10 |
|
City
|
Nashville, TN | PARIS, Ile de France | Austin, TX | |
|
Country
|
United States | France | United States | |
|
Skills & Keywords
Comparing with main company
|
8 Total Skills
Pharmaceutical Manufacturing
AI Therapeutics
Biotechnology
Clinical Trials
Pharmaceuticals
Anxiety Treatment
Autism Research
AI
|
4 Total
4 Unique
Unique Skills:
Big Data
Clinical Records
DNA samples
EMRs
|
23 Total
23 Unique
Unique Skills:
animal health
Assessment
Capital Equipment
Clinical Research Outsourcing
Coaching
Conseil
+17
|
11 Total
11 Unique
Unique Skills:
Artificial Intelligence
Lab Automation
Life Sciences
LIMS
Liquid Handling
LIS
+5
|
Other organizations in the same industry
This company is also known as